Ryvu Therapeutics S.A. (FRA:9Y4)

Germany · Delayed Price · Currency is EUR

6.07

-0.19 (-3.04%)

At close: Jan 30, 2026

Revenue by Product

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Novel Small Molecule Therapies	46.86M
Novel Small Molecule Therapies Growth	20.32%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
European Union Countries	41.66M
European Union Countries Growth	69.25%
Other Countries	5.16M
Other Countries Growth	-63.73%
Poland	38.00K
Poland Growth	-64.15%